Halozyme Therapeutics, Inc.【HALO】 業績推移・財務諸表

(単位:千ドル) 2Q11 3Q11 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 23,188 22,942 7,440 7,757 5,334 21,793 11,833 14,453 16,013 12,498 11,966 18,385 14,606 30,377 18,666 43,384 20,780 52,227 42,499 33,336 31,853 52,227 29,568 33,750 63,731 189,564 30,872 35,202 25,556 60,232 56,949 39,148 46,230 - 25,354 55,221 65,316 - 89,022 136,455 115,830 117,279 152,365 208,976 162,143 221,038 216,033 195,879 231,353 290,084 264,861
売上成長率(%) - - - - - -
売上原価 178 11 70 143 226 - 738 1,283 682 - 5,520 5,924 5,141 - 6,494 8,144 6,180 - 7,762 8,308 9,134 - 7,544 7,788 8,332 - 3,052 836 626 - 4,649 1,877 22,333 - 5,787 5,740 5,568 - 18,219 23,018 18,589 15,922 33,943 47,319 35,170 50,070 54,823 28,329 39,607 49,426 48,403
研究開発費 15,347 13,514 15,891 16,081 19,503 - 22,034 27,990 25,689 - 21,415 18,649 19,904 - 16,684 21,195 27,611 - 40,100 35,530 33,863 - 36,935 38,339 33,993 - 37,976 40,086 35,540 - 31,328 33,910 30,455 - 10,158 8,951 7,747 - 9,009 8,069 8,486 11,853 15,483 16,705 17,979 19,727 17,321 19,111 21,038 18,458 14,799
販売管理費 4,567 4,263 6,618 5,580 5,634 - 7,555 7,299 8,135 - 10,250 8,752 8,587 - 9,399 9,814 10,226 - 10,806 11,221 11,599 - 12,615 13,101 13,329 - 13,556 14,353 14,864 - 18,006 17,338 17,979 - 12,632 10,975 11,702 - 11,059 12,321 13,169 13,834 57,476 34,467 37,357 38,948 35,269 35,134 35,711 41,241 42,362
営業費用 20,093 17,789 22,580 21,805 25,364 26,200 30,329 36,574 34,507 33,822 37,185 33,325 33,632 34,228 32,577 39,153 44,017 46,762 58,668 55,059 54,596 46,762 57,094 59,228 55,654 - 54,584 55,275 51,030 - 53,983 53,125 70,767 - 28,577 25,666 25,017 - 38,287 43,408 40,244 41,609 118,305 125,684 108,341 126,580 127,754 100,337 114,118 126,887 123,326
営業利益 3,095 5,152 -15,141 -14,049 -20,030 - -18,496 -22,121 -18,494 - -25,219 -14,940 -19,026 - -13,911 4,231 -23,237 - -16,169 -21,723 -22,743 - -27,526 -25,478 8,077 - -23,712 -20,073 -25,474 - 2,966 -13,977 -24,537 - -3,223 29,555 40,299 - 50,735 93,047 75,586 75,670 34,060 83,292 53,802 94,458 88,279 95,542 117,235 163,197 141,535
営業利益率 (%) - - - - - - - - -
経常(税引前)利益 - - - - - - - - - - - - - - - - - - - -26,575 -27,662 - -32,687 -30,583 3,329 - -27,274 -22,860 -27,850 - 1,818 -14,607 -25,002 - -6,092 25,875 36,270 - 28,086 91,516 74,106 74,409 30,011 73,707 52,238 93,156 101,760 96,028 117,743 165,147 143,828
経常(税引前)利益率(%) - - - - - - - - - - - - - - - - - - - -79.72 -86.84 - -110.55 -90.62 5.22 - -88.35 -64.94 -108.98 - 3.19 -37.31 -54.08 - -24.03 46.86 55.53 - 31.55 67.07 63.98 63.45 19.7 35.27 32.22 42.14 47.1 49.02 50.89 56.93 54.3
法人税等合計 - - - - - - - - - - - - - - - - - - - 300 1,284 - 210 180 580 - 187 33 0 - 22 17 13 - 11 58 63 - 191 58 -142,481 14,300 7,326 12,100 12,600 18,400 19,900 19,200 24,500 28,100 25,700
実効税率(%) - - - - - - - - - - - - - - - - - - - - - - - -
純利益 3,116 5,165 -15,120 -14,022 -20,006 -4,406 -19,289 -22,912 -19,293 -21,987 -26,548 -16,273 -20,280 -5,274 -15,108 3,019 -24,460 4,318 -19,816 -26,875 -28,946 4,318 -32,897 -30,763 2,749 123,882 -27,461 -22,893 -27,850 -2,126 1,796 -14,624 -25,015 -34,397 -6,103 25,817 36,207 73,164 27,895 91,458 216,587 60,108 22,685 61,634 39,615 74,754 81,837 76,823 93,245 137,011 118,095
純利益率(%) - -
一株あたり利益 0.03 0.05 - - - - - - - - - - - - - 0.02 -0.19 - -0.16 -0.21 -0.23 - -0.26 -0.23 0.02 0.87 -0.19 -0.16 -0.19 -0.01 0.01 - - -0.24 - - 0.27 0.54 0.2 0.64 1.53 0.44 0.16 0.45 0.29 0.57 0.62 0.61 0.73 1.08 0.96
希薄化後一株あたり利益 0.03 0.05 - - - - - - - - - - - - - 0.02 -0.19 - -0.16 -0.21 -0.23 - -0.26 -0.23 0.02 0.85 -0.19 -0.16 -0.19 -0.01 0.01 - - -0.24 - - 0.25 0.5 0.19 0.62 1.48 0.43 0.16 0.44 0.29 0.56 0.61 0.6 0.72 1.05 0.93
EBITDA - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - -